AAN 2025: “Gaming” changes in neuroscience, including MS

AAN highlights noted progress in diagnosis, evidence base, and real-world quality of life measures. For MS, this confirms a “shift to the right” from relapse control to disability progression control.

The 77th Annual Meeting of the American Academy of Neurology (AAN 2025), held April 5-9 in San Diego and online, was an important forum for advancing research in neurology, particularly in neurodegenerative diseases. As one of the largest gatherings of neurologists in the world, the conference provided an important platform for sharing new data, promoting interdisciplinary collaboration, and translating scientific discoveries into clinical strategies.

In the field of neurodegenerative diseases, which includes Alzheimer's disease, Parkinson's disease, multiple sclerosis, and others, AAN 2025 featured influential presentations on gaps in diagnosis, therapeutic development, and treatment. Read more